Bacterial vaccines are developed from killed bacteria or weakened live bacteria that aid in generating antibodies in the body to fight against various harmful bacteria. They provide protection against diseases like tetanus, diphtheria, pertussis, and others. The growing prevalence of diseases like meningitis, measles, pneumonia, and tuberculosis worldwide has increased the demand for effective treatment options like bacterial vaccines. The global Bacterial Vaccines Market is estimated to be valued at US$ 23.77 Bn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends
Development of new vaccines to address unmet medical needs: Major pharmaceutical companies are focusing on developing novel vaccines for diseases that lack effective prevention options. For instance, vaccines targeting Group B Streptococcus (GBS) are under development to prevent GBS infections in newborns. Similarly, vaccine candidates for diseases like tuberculosis, sepsis, gonorrhea are in different stages of clinical trials. This focus on expanding vaccine coverage for more indications is expected to drive the market growth over the forecast period.

Segment Analysis
The bacterial vaccines market is segmented by product into pneumococcal, DTP, influenza, meningococcal, and MMR vaccines. The pneumococcal vaccines segment dominates the market and accounts for over 30% share of the global bacterial vaccines market. This is owing to the high prevalence of pneumococcal diseases and increased government support for routine immunization against pneumococcal infections.

Key Takeaways
 Global Bacterial Vaccines Market Size is expected to witness high growth over the forecast period of 2023 to 2030.

Regional analysis: North America region currently dominates the market due to established healthcare infrastructure and routine immunization programs against bacterial infections. The Asia Pacific region is poised to grow at the fastest pace during the forecast period owing to increasing healthcare spending, rising population, and government initiatives to curb the burden of bacterial diseases.

Key players related content comprises: Key players operating in the bacterial vaccines market are Mondi Group, Kuraray Co. Ltd., Cortec Corporation, Arrow GreenTech Ltd., AMC (UK) Ltd., Aicello Corporation, Sekisui Chemical Co. Ltd., Neptun Technologies GmbH, and Mitsubishi Chemical Corporation, among others. The market is dominated by large scale players like Mondi Group and Kuraray Co. Ltd. that leverage economies of scale in manufacturing and distribution and have strong global footprints across major regions.

Get More Insights On This Topic: https://www.newsanalyticspro.com/bacterial-vaccines-market-propelled-by-development-of-new-vaccines/